Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications. [electronic resource]
Producer: 20181127Description: 365-378 p. digitalISSN:- 1790-6245
- Antineoplastic Agents -- adverse effects
- Axitinib
- Carcinoma, Renal Cell -- drug therapy
- DNA Copy Number Variations -- genetics
- Drug Resistance, Neoplasm -- genetics
- Female
- Genome, Human -- drug effects
- Glioblastoma -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Indazoles -- therapeutic use
- Indoles -- therapeutic use
- Male
- Molecular Targeted Therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Pyrroles -- therapeutic use
- Sorafenib
- Sunitinib
- Vascular Endothelial Growth Factor Receptor-1 -- genetics
- Vascular Endothelial Growth Factor Receptor-3 -- genetics
- fms-Like Tyrosine Kinase 3 -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.